Why Single-Agent GLP-1 Therapy May Deliver Superior Results Clinical trials demonstrate that semaglutide monotherapy produces sustained weight loss averaging 1015% of baseline body weight over 68 weeks, with continued improvement at higher doses and extended treatment duration
In contrast, metformin works much faster
Differential diagnoses including infection, structural pathology, anemia, thyroid dysfunction, and medication interactions were all excluded
However, molecular degradation often occurs without visible changes
Williams says now, she feels better than ever with more energy and less joint pain
The medication has increased significantly in popularity, with demand being so great that it has impacted the availability of the drug